Sign In

Jennifer Leeds

Executive Director, Head BD&L Search and Evaluation, West Coast and Canada, Translational Medicine, and Oncology at Novartis

Professional Background

Jennifer Leeds is a highly regarded business-minded scientific leader with a wealth of experience in the bio-pharmaceutical industry, academia, and investor communities. Her intricate understanding of business development strategy and her expertise in identifying and capitalizing on licensing opportunities has positioned her as a trusted senior leader within her field. With an ability to build high-value organizations and a proven track record of developing and retaining top talent, Jennifer excels in navigating the complexities of leadership within matrix environments. Her role often entails advising on and executing highly sensitive, strategic decisions and projects, making her a vital asset to any organization.

Throughout her esteemed career, Jennifer has demonstrated extensive experience in setting the strategic direction and executing portfolio management from target discovery all the way through to clinical stages. This breadth of knowledge is complemented by her proficiency in leading restructuring and reorganizations, showcasing her expertise in change management processes—an essential skill in an ever-evolving industry.

Communication and Engagement

Jennifer is particularly adept at conveying organizations’ scientific premises and strategies compellingly and inspiringly. She is deeply engaged with various stakeholders, both internally and externally, and is often invited to speak at leading scientific meetings. Her roles as an organizer, mentor, instructor, and author further illustrate her commitment to communication and collaboration in the scientific community. Her ability to inspire and educate extends beyond her immediate professional network, influencing a wider audience across the biotechnology field.

Education and Achievements

Jennifer’s educational journey laid a strong foundation for her distinguished career in science. She completed her postdoctoral fellowship in microbiology and molecular genetics at Harvard Medical School, where she honed her skills in research and collaborative work. Following her fellowship, she earned her Ph.D. in Microbiology from the University of Wisconsin-Madison, an institution known for its rigorous academic environment and commitment to scientific advancement. Her academic journey began with a Bachelor of Science degree in Microbiology from Cornell University, which equipped her with the essential knowledge needed to excel in her future endeavors.

Notable Contributions

In addition to her academic excellence, Jennifer’s contributions in the bio-pharmaceutical realm are noteworthy. She is recognized as a co-inventor and a leader of international discovery project teams and has made significant contributions to the clinical development of the novel drug LFF571. Her expertise spans bacterial genetics and physiology, as well as antibacterial mechanisms of action and resistance, clinical microbiology, drug discovery, and clinical development. Such skills make her an invaluable expert in the biomedical landscape, capable of addressing some of the most pressing health challenges of our time.

Professional Roles and Leadership

Jennifer holds the esteemed position of Executive Director, Head of Business Development and Licensing (BD&L) for the West Coast and Canada at Novartis Institutes for BioMedical Research (NIBR), focusing on Translational Medicine and Oncology. Her leadership encompasses expansive responsibilities where she guides strategic decisions that align with the organization's mission of delivering breakthrough treatments to patients.

Her extensive professional journey at Novartis has seen Jennifer rise through the ranks across a span of various vital roles where her impact has been felt at every level. She has served as a Senior Research Investigator, Research Investigator II and I, and Executive Director in crucial areas such as Antibacterial Discovery. Each role has allowed her to share her knowledge and influence the direction of numerous projects, thereby reinforcing Novartis’s position as a leader in the bio-pharmaceutical space.

Moreover, Jennifer has been actively involved with numerous organizations beyond her immediate responsibilities at Novartis. Her experiences as an Independent Director at 1910 Genetics, Board Observer at Bluejay Therapeutics, and her advisory roles with various scientific and innovation organizations signal her commitment to fostering growth and innovation within the biotechnology community. Her involvement with the Council of Founders at imYEG and as an Expert Advisor at the California Life Sciences Institute underscores her valuable contributions to enhanced collaboration and acceleration of life sciences advancement.

Mentorship and Community Engagement

A passionate mentor, Jennifer invests her skills in nurturing the next generation of scientists and leaders within the industry. She has shared her extensive expertise through mentoring, teaching, and engaging with graduate trainees, demonstrating her belief in knowledge sharing and development. Whether through formal mentorship programs or informal coaching, her support empowers aspiring professionals to pursue their scientific and business aspirations confidently.

Additionally, her authorial contributions help disseminate crucial knowledge within the life sciences sector, further solidifying her role as an influential thought leader. Jennifer’s position as a keynote speaker at various scientific meetings not only highlights her status as a respected figure in science but also emphasizes her dedication to inspiring others.

In summary, Jennifer Leeds is a dedicated and accomplished professional whose significant contributions to the bio-pharmaceutical industry enhance our understanding of microbial resistance and innovation in drug development. With an illustrious academic background and extensive professional experience, Jennifer continuously exemplifies leadership, mentorship, and strategic acumen in her work. As she navigates the complexities of the bio-pharmaceutical landscape, her commitment to advancing scientific research and fostering collaboration shines through, making her a prominent and trusted figure in her field.

Related Questions

How did Jennifer Leeds become an expert in business development strategy within the bio-pharmaceutical industry?
What impact has Jennifer Leeds had on strategic decisions at Novartis Institutes for BioMedical Research?
In what ways does Jennifer Leeds mentor emerging scientists in the biotechnology field?
How has Jennifer Leeds's educational background shaped her career in microbiology and molecular genetics?
What are some of the notable projects Jennifer Leeds led in her role at Novartis?
Jennifer Leeds
Add to my network

Location

Emeryville, California, United States